Genedata Biopharma Partner Symposium 2022
Agenda
| Day 1 – Wednesday, March 23, 2022 | |||
|---|---|---|---|
| Plenary Session | |||
| 8:30–9:00 | Registration & Welcome Coffee Hyperion Hotel 3rd Floor, Messeplatz 12, Basel, Switzerland | ||
| 9:00–9:10 | Opening Remarks Jana Hersch, Ph.D., Scientific Consultant, Genedata, Basel, Switzerland | ||
| 9:10–9:30 | Challenges in Digitalizing Biopharma R&D Othmar Pfannes, Ph.D., CEO, Genedata, Basel, Switzerland | ||
| 9:30–10:00 | Biologics Discovery at Novartis – Synergies Within and Beyond the Biopharma Platform Markus Kroemer, Ph.D., Associate Director Data Science, Novartis, Basel, Switzerland Björn Hüber, Team Leader Data Management, Novartis – NIBR Biologics Center, Basel, Switzerland | ||
| 10:00–10:30 | AstraZeneca’s 10 Years of Partnership with Genedata – Innovation, Efficiency, Reliability Jonathan Wingfield, Ph.D., Principal Scientist, AstraZeneca, Cambridge, UK | ||
| 10:30–11:00 | Break | ||
| Break-out Sessions | |||
| BIOLOGICS Biologics Discovery | SCREENER Discovery Screening | EXPRESSIONIST Mass-Spec Analytics | |
| 11:00–11:30 | Enabling Discovery – Enriching Data Analysis for Biologics at Merck Sameh Eid, Ph.D., Principal Scientist, Research Informatics, Merck Healthcare KGaA, Darmstadt, Germany | Implementation of Genedata Screener for Drug Discovery at Lundbeck Alexander Cahlin, Research Assistant, Lundbeck, Valby, Denmark | From MS-Based Characterization to Automated Data Treatment for ADCs and Oligonucleotides Anthony Ehkirch, Ph.D., Principal Scientist, Novartis, Basel, Switzerland |
| 11:30–12:00 | Janssen's High-Throughput Biopharma R&D in the Digital Age Kimberly Munsell, Senior CSV and Compliance Manager, Janssen, Spring House, PA, USA | Digitalization of R&D at Roche – Challenges, Progress, and Outlook Romel Bobby, Ph.D., Senior Scientist, Roche, Basel, Switzerland Anastasios Moresis, Ph.D., Senior Scientist, Roche, Basel, Switzerland | High-Throughput Protein Analysis and Reporting in Industrial Biotechnology Anders Giessing, Ph.D., Senior Scientist, Novozymes, Bagsvaerd, Denmark |
| 12:00–13:30 | Lunch | ||
| 13:30–14:00 | Pfizer’s New mRNA Workflows for Vaccines and Therapeutics Joel Bard, Ph.D., Associate Research Fellow, BioMedicine Design, Pfizer, Cambridge, MA, USA | Application of High Throughput Cellular Thermal Shift Assays (HT-CETSA) in Early Drug Discovery Felix Baerenz, Ph.D., Lab Head, In Vitro Biology, Sanofi, Frankfurt, Germany | RP-MAM and HILIC-MAM – A Combined Approach for Highly Glycosylated Fusion Protein Melanie Jakobczyk, Associate Scientist, Biotech Process Sciences, Merck Healthcare, Corsier-sur-Vevey, Switzerland |
| 14:00–14:30 | Analytical Workflow Integration in Genedata Biologics Samuel Cheng, Ph.D., IS Lead Business Consultant, IT RDM Research, Boehringer Ingelheim Pharmaceuticals Inc., Ridgefield, CT, USA | High-Throughput Covalent Fragment Screening with MALDI Mass Spectrometry Don Nguyen, Ph.D., High Throughput Mass Spectrometrist, Bioassay Automation, Discovery Pharmacology, Merck Healthcare KGaA, Darmstadt, Germany | HCP Analysis of Scale Down Model Processes William Burkitt, Ph.D., Associate Director, UCB, Slough, UK |
| 14:30–15:00 | Genedata Biologics at Takeda – Adoption and Building Tools for Data Upload Prashanth Vishwanath, Ph.D., Associate Director, Global Biologics, Takeda, Cambridge, MA, USA | A Hitchhiker’s Guide to the Biophysics Galaxy – Positioning SPR on the Drug Discovery Map Christine Genick, Ph.D., Principal Scientist II, Lab Head, Novartis, Basel, Switzerland | Open Discussion The Future of Mass Spectrometry in the Biopharma Industry |
| Plenary Session | |||
| 15:10–15:40 | Utilizing Translational Data Science to Improve Drug Development and Treatment of Patients Sriram Sridhar, Ph.D, Director, Translational Data Science, Genmab, Princeton, NJ, USA | ||
| 15:40–16:00 | Break | ||
| 16:00–18:00 | Demo & Poster Session Meet the Experts – Check out our demos and view posters. Demos are approximately 5–10 minutes and will be repeated on demand throughout the session | ||
| 19:30–21:30 | Group Dinner | ||
| Day 2 – Thursday, March 24, 2022 | ||||
|---|---|---|---|---|
| Plenary Session | ||||
| 8:30–9:00 | Welcome Coffee | |||
| 9:00–9:15 | Opening Remarks Jana Hersch, Ph.D., Scientific Consultant, Genedata, Basel, Switzerland | |||
| 9:15–9:45 | Sharing Experiences with the Implementation of Genedata BioPharma at Genmab Rik Rademaker, Ph.D., Director Cell and Molecular Sciences, Genmab, Utrecht, The Netherlands | |||
| Break-out Sessions | ||||
| BIOLOGICS Biologics Discovery | SCREENER Discovery Screening | BIOPROCESS Bioprocess Development | SELECTOR NGS-Driven Biosafety | |
| 9:45–10:15 | The Evolution of Novartis' Biologics Platform – Technical Developments Desmond Fox, NX Business Analyst, Novartis – NIBR Biologics Center, Basel, Switzerland Drazen Nadoveza, Ph.D., Senior Principal Software Engineer, Novartis – NIBR Biologics Center, Basel, Switzerland | Implementation of Genedata Screener at Servier Anne-Laure Ong, Screening Team Leader, Servier, Croissy, France | NGS-Based Methods for the Characterization of Gene Knockouts Rico Uhler, Ph.D., Group Manager Automation and Data Management, Octapharma, Heidelberg, Germany | |
| 10:15–10:45 | Break | |||
| 10:45–11:15 | Genedata Biologics at Charles River – Supporting End-to-End Biologics Discovery Maurice Brozzo, Ph.D., European Antibody Discovery Business Development Manager, Charles River Laboratories, Zurich, Switzerland | Evotec’s RT-qPCR Data Analysis Workflow for Accelerated RNA-Targeted Drug Discovery Romain Chassefeyre, Ph.D., Project and Team Lead, Evotec, Toulouse, France Xavier Marechal, Ph.D., Project and Team Lead, Evotec, Toulouse, France | Data View Customization and Report Automation with Genedata Bioprocess Markus Sanna, Manager Digital Data Excellence and IT Services, Sartorius Stedim Cellca GmbH, Ulm, Germany | Validation Data to Support NGS Purity Testing of Veterinary Master Seeds Blandine de Saint-Vis, Ph.D., Global MSAT Bio-Analytics – Senior Scientist, Boehringer Ingelheim Animal Health, Saint-Priest, France |
| 11:15–11:45 | Genedata Biologics – Benchling ELN Integration at Agenus Andreas Arnell, Laboratory Informatics Manager, Agenus, Cambridge, UK | AI at Your Fingertips – Automation of High Content Screening Analysis with Genedata Imagence 5.0 Cameron Scott, Scientific Account Manager, Genedata, Basel, Switzerland | Genedata in AgTech – From Clone Pool to Food Protection Dominique Vlieghe, Ph.D., Data and Information Manager, Biotalys, Ghent, Belgium | A Newly Identified Small RNA Regulates NGNA Sialylation in CHO Cells Moritz Schmidt, Ph.D., Head of Laboratory Molecular Biology, Boehringer-Ingelheim, Ulm, Germany |
| 11:45–13:15 | Lunch | |||
| Plenary Session | ||||
| 13:15–13:45 | Genedata Biologics-Supported Workflows for HT Screening of Multi-Specifics: Recent Advances and Future Perspectives Dilyana Dimova, Ph.D., Senior Data Scientist, Sanofi, Frankfurt, Germany | |||
| 13:45–14:15 | Genedata Current and Future Solutions for Automation Laboratories Sascha Fischer, Business Development Automation, Genedata, Basel, Switzerland | |||
| 14:15–14:45 | Path to Precision Medicine – Connecting People and Data Tamas Rujan, Head of Genedata Profiler, Business, Basel, Switzerland Marc Flesch, Ph.D., Head of Genedata Profiler, Product, Munich, Germany | |||
| 14:45–15:00 | Closing Remarks Othmar Pfannes, Ph.D., CEO, Genedata, Basel, Switzerland | |||
| 15:00–15:30 | Post Symposium Open Discussion & Farewell Coffee | |||
| End of Symposium | ||||